1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Melasma Drug Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Melasma Drug Treatment Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Disease Epidemiology
5.3. Regulatory Scenario
5.4. Pipeline Analysis
5.5. Covid-19 Impact Analysis
6. Global Melasma Drug Treatment Market Analysis and Forecast, by Type of Melasma
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type of Melasma, 2017-2031
6.3.1. Epidermal Melasma
6.3.2. Dermal Melasma
6.3.3. Mixed Melasma
6.4. Market Attractiveness Analysis, by Type of Melasma
7. Global Melasma Drug Treatment Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Route of Administration, 2017-2031
7.3.1. Topical
7.3.2. Oral
7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Melasma Drug Treatment Market Analysis and Forecast, by Gender
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Gender, 2017-2031
8.3.1. Men
8.3.2. Women
8.4. Market Attractiveness Analysis, by Gender
9. Global Melasma Drug Treatment Market Analysis and Forecast, by Drug Agent
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Drug Agent, 2017-2031
9.3.1. Hydroquinone
9.3.2. Topical Retinoid
9.3.3. Topical Steroid
9.3.4. Triple Combination Cream
9.3.5. Others
9.4. Market Attractiveness Analysis, by Drug Agent
10. Global Melasma Drug Treatment Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Offline
10.3.2. Online
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Melasma Drug Treatment Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Melasma Drug Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type of Melasma, 2017-2031
12.2.1. Epidermal Melasma
12.2.2. Dermal Melasma
12.2.3. Mixed Melasma
12.3. Market Value Forecast, by Route of Administration, 2017-2031
12.3.1. Topical
12.3.2. Oral
12.4. Market Value Forecast, by Gender, 2017-2031
12.4.1. Men
12.4.2. Women
12.5. Market Value Forecast, by Drug Agent, 2017-2031
12.5.1. Hydroquinone
12.5.2. Topical Retinoid
12.5.3. Topical Steroid
12.5.4. Triple Combination Cream
12.5.5. Others
12.6. Market Value Forecast, by Distribution Channel, 2017-2031
12.6.1. Offline
12.6.2. Online
12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type of Melasma
12.8.2. By Route of Administration
12.8.3. By Gender
12.8.4. By Drug Agent
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Melasma Drug Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type of Melasma, 2017-2031
13.2.1. Epidermal Melasma
13.2.2. Dermal Melasma
13.2.3. Mixed Melasma
13.3. Market Value Forecast, by Route of Administration, 2017-2031
13.3.1. Topical
13.3.2. Oral
13.4. Market Value Forecast, by Gender, 2017-2031
13.4.1. Men
13.4.2. Women
13.5. Market Value Forecast, by Drug Agent, 2017-2031
13.5.1. Hydroquinone
13.5.2. Topical Retinoid
13.5.3. Topical Steroid
13.5.4. Triple Combination Cream
13.5.5. Others
13.6. Market Value Forecast, by Distribution Channel, 2017-2031
13.6.1. Offline
13.6.2. Online
13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
13.7.1. U.K.
13.7.2. Germany
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type of Melasma
13.8.2. By Route of Administration
13.8.3. By Gender
13.8.4. By Drug Agent
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Melasma Drug Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type of Melasma, 2017-2031
14.2.1. Epidermal Melasma
14.2.2. Dermal Melasma
14.2.3. Mixed Melasma
14.3. Market Value Forecast, by Route of Administration, 2017-2031
14.3.1. Topical
14.3.2. Oral
14.4. Market Value Forecast, by Gender, 2017-2031
14.4.1. Men
14.4.2. Women
14.5. Market Value Forecast, by Drug Agent, 2017-2031
14.5.1. Hydroquinone
14.5.2. Topical Retinoid
14.5.3. Topical Steroid
14.5.4. Triple Combination Cream
14.5.5. Others
14.6. Market Value Forecast, by Distribution Channel, 2017-2031
14.6.1. Offline
14.6.2. Online
14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type of Melasma
14.8.2. By Route of Administration
14.8.3. By Gender
14.8.4. By Drug Agent
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Melasma Drug Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type of Melasma, 2017-2031
15.2.1. Epidermal Melasma
15.2.2. Dermal Melasma
15.2.3. Mixed Melasma
15.3. Market Value Forecast, by Route of Administration, 2017-2031
15.3.1. Topical
15.3.2. Oral
15.4. Market Value Forecast, by Gender, 2017-2031
15.4.1. Men
15.4.2. Women
15.5. Market Value Forecast, by Drug Agent, 2017-2031
15.5.1. Hydroquinone
15.5.2. Topical Retinoid
15.5.3. Topical Steroid
15.5.4. Triple Combination Cream
15.5.5. Others
15.6. Market Value Forecast, by Distribution Channel, 2017-2031
15.6.1. Offline
15.6.2. Online
15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type of Melasma
15.8.2. By Route of Administration
15.8.3. By Gender
15.8.4. By Drug Agent
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Melasma Drug Treatment Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type of Melasma, 2017-2031
16.2.1. Epidermal Melasma
16.2.2. Dermal Melasma
16.2.3. Mixed Melasma
16.3. Market Value Forecast, by Route of Administration, 2017-2031
16.3.1. Topical
16.3.2. Oral
16.4. Market Value Forecast, by Gender, 2017-2031
16.4.1. Men
16.4.2. Women
16.5. Market Value Forecast, by Drug Agent, 2017-2031
16.5.1. Hydroquinone
16.5.2. Topical Retinoid
16.5.3. Topical Steroid
16.5.4. Triple Combination Cream
16.5.5. Others
16.6. Market Value Forecast, by Distribution Channel, 2017-2031
16.6.1. Offline
16.6.2. Online
16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type of Melasma
16.8.2. By Route of Administration
16.8.3. By Gender
16.8.4. By Drug Agent
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. AbbVie Inc.
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. GALDERMA
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. Obagi Cosmeceuticals LLC.
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Valeant Pharmaceuticals
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. GLENMARK PHARMACEUTICALS LTD
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Abbott
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. La Pristine
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. MESOESTETIC
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
Table 01: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 02: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 03: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 04: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 05: Global Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 06: Global Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 09: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 10: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 11: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 12: North America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 13: Europe Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 15: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 16: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 17: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 18: Europe Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 19: Asia Pacific Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 21: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 22: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 23: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 24: Asia Pacific Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 25: Latin America Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 27: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 28: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 29: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 30: Latin America Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 31: Middle East and Africa Melasma Drug Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Type of Melasma, 2017-2031
Table 33: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 34: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Drug Agent, 2017-2031
Table 35: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Gender, 2017-2031
Table 36: Middle East and Africa Melasma Drug Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
